Vir Biotechnology, Inc. Gross Profit 2017–2025
Vir Biotechnology, Inc. reported $68.53M of gross profit for fiscal 2025. That was 6.6% lower than fiscal 2024. Compared with fiscal 2021, the change was -93.3%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $68.53M | 100.0% | -6.6% |
| FY 2024 | $73.36M | 98.9% | -12.1% |
| FY 2023 | $83.42M | 96.8% | -94.3% |
| FY 2022 | $1.47B | 90.9% | +42.7% |
| FY 2021 | $1.03B | 94.0% | — |
| FY 2020 | — | — | — |
| FY 2019 | — | — | — |
| FY 2018 | — | — | — |
| FY 2017 | — | — | — |
Source: Vir Biotechnology, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open VIR 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Vir Biotechnology, Inc. reported $68.53M of gross profit for fiscal 2025. That was 6.6% lower than fiscal 2024. Compared with fiscal 2021, the change was -93.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Vir Biotechnology, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVir Biotechnology, Inc. — frequently asked questions
What is Vir Biotechnology, Inc.'s gross profit?
Vir Biotechnology, Inc. (VIR) reported gross profit of $68.53M for fiscal year 2025, per its SEC filings.
How has Vir Biotechnology, Inc.'s gross profit changed over time?
Between fiscal 2017 and 2025, VIR's gross profit declined at roughly 28.7% per year (compound annual rate), from $1.03B to $68.53M.
Where does this data come from?
Figures are computed from Vir Biotechnology, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.